|
Volumn 18, Issue 5, 2004, Pages 825-827
|
Yellow fever vaccine is safe and effective in HIV-infected patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD4 ANTIGEN;
CD8 ANTIGEN;
NEUTRALIZING ANTIBODY;
YELLOW FEVER VACCINE;
ADULT;
ANTIBODY BLOOD LEVEL;
ANTIBODY RESPONSE;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
FEVER;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION PREVENTION;
LYMPHOCYTE COUNT;
MALE;
PHARYNGITIS;
PRIORITY JOURNAL;
STATISTICAL SIGNIFICANCE;
T LYMPHOCYTE;
VACCINATION;
VIRUS LOAD;
YELLOW FEVER;
YELLOW FEVER FLAVIVIRUS;
ADULT;
ANTIBODIES, VIRAL;
CD4 LYMPHOCYTE COUNT;
FEMALE;
HIV INFECTIONS;
HIV-1;
HUMANS;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
VIRAL LOAD;
YELLOW FEVER;
YELLOW FEVER VACCINE;
|
EID: 2042503029
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-200403260-00020 Document Type: Article |
Times cited : (67)
|
References (8)
|